Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ)
CNY 9.12
(-0.44%)
CNY 9.12
(-0.44%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.81 Billion CNY | -4.76% |
| 2022 | 5.05 Billion CNY | 8.15% |
| 2021 | 4.67 Billion CNY | 15.64% |
| 2020 | 4.04 Billion CNY | 55.85% |
| 2019 | 2.59 Billion CNY | 18.18% |
| 2018 | 2.19 Billion CNY | 22.75% |
| 2017 | 1.78 Billion CNY | 27.96% |
| 2016 | 1.39 Billion CNY | 38.5% |
| 2015 | 1 Billion CNY | 59.67% |
| 2014 | 632.34 Million CNY | 16.82% |
| 2013 | 541.3 Million CNY | 13.65% |
| 2012 | 476.3 Million CNY | 35.1% |
| 2011 | 352.56 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 4.64 Billion CNY | -0.66% |
| 2024 Q1 | 4.71 Billion CNY | -2.21% |
| 2024 Q2 | 4.67 Billion CNY | -0.69% |
| 2023 Q3 | 4.92 Billion CNY | -0.49% |
| 2023 Q4 | 4.81 Billion CNY | -2.16% |
| 2023 Q1 | 4.86 Billion CNY | -3.84% |
| 2023 FY | 4.81 Billion CNY | -4.76% |
| 2023 Q2 | 4.94 Billion CNY | 1.73% |
| 2022 Q4 | 5.05 Billion CNY | -0.71% |
| 2022 Q3 | 5.09 Billion CNY | 1.3% |
| 2022 Q2 | 5.03 Billion CNY | 1.56% |
| 2022 FY | 5.05 Billion CNY | 8.15% |
| 2022 Q1 | 4.95 Billion CNY | 5.88% |
| 2021 Q1 | 4.23 Billion CNY | 4.79% |
| 2021 Q3 | 4.47 Billion CNY | 2.89% |
| 2021 Q4 | 4.67 Billion CNY | 4.58% |
| 2021 FY | 4.67 Billion CNY | 15.64% |
| 2021 Q2 | 4.34 Billion CNY | 2.56% |
| 2020 Q1 | 2.87 Billion CNY | 10.9% |
| 2020 FY | 4.04 Billion CNY | 55.85% |
| 2020 Q4 | 4.04 Billion CNY | 37.15% |
| 2020 Q3 | 2.94 Billion CNY | 2.0% |
| 2020 Q2 | 2.89 Billion CNY | 0.46% |
| 2019 Q2 | 2.54 Billion CNY | 0.55% |
| 2019 Q1 | 2.52 Billion CNY | 15.05% |
| 2019 FY | 2.59 Billion CNY | 18.18% |
| 2019 Q4 | 2.59 Billion CNY | -0.78% |
| 2019 Q3 | 2.61 Billion CNY | 2.96% |
| 2018 Q3 | 2.05 Billion CNY | -1.81% |
| 2018 Q2 | 2.08 Billion CNY | 10.62% |
| 2018 Q1 | 1.88 Billion CNY | 5.58% |
| 2018 FY | 2.19 Billion CNY | 22.75% |
| 2018 Q4 | 2.19 Billion CNY | 7.03% |
| 2017 Q3 | 1.72 Billion CNY | 5.18% |
| 2017 Q4 | 1.78 Billion CNY | 3.73% |
| 2017 Q2 | 1.63 Billion CNY | 9.22% |
| 2017 Q1 | 1.5 Billion CNY | 7.38% |
| 2017 FY | 1.78 Billion CNY | 27.96% |
| 2016 Q2 | 1.14 Billion CNY | 13.31% |
| 2016 Q4 | 1.39 Billion CNY | 15.65% |
| 2016 Q3 | 1.2 Billion CNY | 5.86% |
| 2016 Q1 | 1 Billion CNY | -0.16% |
| 2016 FY | 1.39 Billion CNY | 38.5% |
| 2015 Q3 | 717.57 Million CNY | 5.47% |
| 2015 FY | 1 Billion CNY | 59.67% |
| 2015 Q4 | 1 Billion CNY | 40.7% |
| 2015 Q1 | 658.44 Million CNY | 4.13% |
| 2015 Q2 | 680.35 Million CNY | 3.33% |
| 2014 Q4 | 632.34 Million CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 FY | 632.34 Million CNY | 16.82% |
| 2013 FY | 541.3 Million CNY | 13.65% |
| 2012 FY | 476.3 Million CNY | 35.1% |
| 2011 FY | 352.56 Million CNY | 0.0% |